Thyroid hormones are important for mammary gland growth and development. The iodothyronine deiodinases play a key role in thyroid hormone metabolism. We have showed that type II 5Ј-deiodinase (5ЈD2) activity and mRNA are present in the mouse mammary gland and that their levels are reduced in the lactating gland. To investigate the regulatory mechanism of mouse 5ЈD2 gene (mdio2) expression in mammary epithelium, we employed the HC11 cell line, which is derived from mouse mammary epithelial cells and retains the ability to express differentiated function. HC11 cells were treated with combinations of insulin, glucocorticoid (GC, dexamethasone), prolactin, and epidermal growth factor (EGF), and 5ЈD2 activity and the D2-to-GAPDH mRNA ratio were measured by 125 I Ϫ release from 125 I-labeled thyroxine and semiquantitative RT-PCR, respectively. EGF increased both 5ЈD2 activity and mRNA levels about twofold. GC reduced both 5ЈD2 activity and mRNA in a dose-dependent manner, and their levels were decreased to approximately one-tenth and onefifth, respectively, of control levels. These data demonstrated that mdio2 expression in HC11 cells is upregulated by EGF mainly at the pretranslational level and downregulated by GC at both pre-and posttranslational levels. Furthermore, we showed that GC reduced the promoter activity of the 627-bp 5Ј-upstream region of the mdio2/luciferase chimeric reporter gene, suggesting that GC exerts its effect, at least in part, at the transcriptional level.
type II iodothyronine deiodinase; HC11 cells; mammary gland; epithelial growth factor; promoter activity THE GROWTH AND DEVELOPMENT of the mammary gland are regulated by synergic action of hormones and growth factors, such as prolactin (PRL), glucocorticoid (GC), insulin, placental lactogen, and epidermal growth factor (EGF) (24, 25, 33) . Thyroid hormones (TH) are also important for mammary growth and development (32, 34, 36) . It has been reported that TH-specific binding is present in the nucleus as well as in the cytosol fraction in mouse mammary tissue (28) . TH stimulate mammary gland growth and development in vivo as well as in vitro (34, 36) . Administration of thyroxine (T 4 ) to pregnant and lactating rats increases the synthesis of milk proteins in the mammary gland (26) . On the other hand, administration of an excess amount of 3,3Ј,5-triiodothyronine (T 3 ) to pregnant and lactating rats decreases milk production (20) . These results are not consistent and thus need to be clarified to determine the importance of T 3 production within the mammary gland.
The iodothyronine deiodinases are important for the metabolism of TH (6, 18, 19) . 5Ј-Deiodinase (5ЈD), which catalyzes T 4 to the most active form, T 3 , has two distinct isoforms, type I (5ЈD1) and type II (5ЈD2). 5ЈD1 has a high K m value, whereas 5ЈD2 exhibits a higher catalytic activity (17, 19, 35) . It has been reported that 5ЈD1 activity and mRNA are present in the lactating rat mammary gland (2, 23) . Although another report showed that 5ЈD1 was expressed in the lactating mouse mammary gland, 5ЈD1 activity was at a very low level compared with that in the rat (7) . On the other hand, 5ЈD2 is the predominant form in the lactating cow and pig mammary gland (16, 29) . Our previous study (31) has shown that 5ЈD2 activity and mRNA are present in the mouse mammary gland and that their levels in the lactating mouse mammary gland are lower than those in the virgin and pregnant animals. Studies of the mechanism regulating 5ЈD should provide useful information for the function and metabolism of TH in the mammary gland.
The HC11 cell line, which is derived from epithelial cells of the BALB/C mouse mammary gland, exhibits the ability to differentiate and produce a major milk protein, ␤-casein, in response to the lactogenic hormones insulin, GC, and PRL (4) . In the present study, we employed this cell line to investigate the hormonal control of 5ЈD2 activity and mRNA. We found that EGF upregulated mouse 5ЈD2 gene (mdio2) expression mainly at the pretranslational level and that GC downregulated mdio2 expression at both pre-and posttranslational levels in HC11 cells. Furthermore, we showed that GC downregulated the promoter activity of the 5Ј-upstream region of mdio2 in HC11 cells, suggesting the transcriptional regulation of mdio2 expression by GC. Cell culture. HC11 cells were grown in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS; Life Technologies, Rockville, MD), antibiotics, 5 g/ml insulin, and 10 ng/ml EGF (4). Cells were propagated on 60-mm dishes or 6-well plates for 5ЈD assay or RNA preparation, respectively. Two days after reaching confluence, cells were treated with various combinations of 5 g/ml insulin, 10 ng/ml EGF, 5 g/ml PRL, and 1 M dexamethasone in RPMI 1640 medium supplemented with 10% FCS for 2 days. Some cells were treated without hormones and EGF and used as controls.
MATERIALS AND METHODS

Materials
5ЈD assay. HC11 cells were washed twice with cold PBS, harvested, sonicated in a buffer (0.25 M sucrose in 0.02 mM Tris buffer, pH 7.4, containing 1 mM EDTA and 10 mM DTT), and stored at Ϫ70°C. The protein concentration of sonicates was measured by a protein assay kit (Bio-Rad Laboratories, Hercules, CA). 5ЈD2 assay was performed as described previously (31) . Briefly, the substrate, [
125 I]T4, was purified using an AG50W-X8 column (Bio-Rad Laboratories). Samples (50-150 g protein), 0.1 M phosphate buffer (pH 7.0), 2 nM [ 125 I]T4 (ϳ2 ϫ 10 5 counts/min), 1 mM EDTA, 25 mM DTT, and 1 mM PTU in a final volume of 500 l were incubated at 37°C for 3 h. The release of 125 I Ϫ in the reaction mixture was measured after it was passed through a small AG50W-X8 column. Background controls containing no enzyme sample were always included in the assay, and net radioactivity was determined by subtracting the value obtained by background controls from that by enzyme samples. 5ЈD2 activity is expressed as femtomoles per milligram protein per hour. The amount of 125 I Ϫ released was Ͻ30% of total radioactivity in the reaction mixture. The 125 I Ϫ release was linear for 6 h and also linear with increasing protein concentrations. 5ЈD1 activity was assayed using 2 nM [ 125 I]rT3, 0.5 M nonradiolabeled rT3, and other reagents as described (1) .
RNA preparation and RT-PCR analysis. Total RNA was isolated using TRIzol Reagent (Life Technologies) according to the manufacturer's instructions. RT-PCR was carried out with an RT-PCR kit obtained from Perkin-Elmer (Foster City, CA), as described previously (31) . Briefly, 2 g of total RNA were reverse-transcribed using random hexamers and MuLV reverse transcriptase in a 40-l reaction volume at 42°C for 30 min. Five microliters of these reactions were then used in PCR in a 25-l volume of reaction mixture under the following conditions: 1 cycle of 95°C ϫ 1 min, 34 cycles of 94°C ϫ 30 s, 57°C ϫ 40 s, 72°C ϫ 1 min, and a final 10-min extension period, except for GAPDH, which was performed for 22 cycles. Primers used were as follows: mouse 5ЈD1 sense primer, 5Ј-GCACCTGACCTTCATTTCTT-3Ј; antisense primer, 5Ј-CTGGCTGCTCTGGTTCTG-3Ј (GenBank accession no. MMU49861) (21) ; mouse 5ЈD2 sense primer, 5Ј-ACTCGGT-CATTCTGCTCAAG-3Ј; antisense primer, 5Ј-TTCAAAGGC-TACCCCGTAAG-3Ј (AF093137, AF096875) (10, 31); mouse type III deiodinase (D3) sense primer, 5Ј-CTAGGCACGGC-CTTCATGCTCTGGC-3Ј; antisense primer, 5Ј-ATCATAG-CGCTCCAACCAAGTGCGC-3Ј (AF426023) (11) . Mouse ␤-casein primers were 5Ј-ACTACATTTACTGTATCCTCTGA-3Ј and 5Ј-GTGCTACTTGCTGCAGAAAGTACAG-3Ј (X04490) (37) . The primer set for GAPDH was purchased from Clontech (Palo Alto, CA). PCR products were analyzed by electrophoresis on a 1.5% agarose gel containing ethidium bromide. RT-PCR without reverse transcriptase and PCR using H 2O as a template were carried out as negative controls.
Semiquantitative RT-PCR analysis was performed by the method described previously (31) . RT-PCR was carried out as described above, with 5 pmol of each primer set for mouse 5ЈD2 and GAPDH in one tube for 20 cycles. 5ЈD2 sense and GAPDH sense primers were 5Ј-end labeled with [␥-32 P]dATP. At least one sample in each group was applied to PCR for 18-22 cycles to confirm that the amplification of the products increased exponentially with respect to the PCR cycles. PCR products were electrophoresed on a 3.5% polyacrylamide gel. After autoradiography, each band of PCR products corresponding to 5ЈD2 and GAPDH was cut, and the radioactivities were counted. The radioactivities of the 5ЈD2 band were normalized to those of the GAPDH band and expressed as a 5ЈD2-to-GAPDH (D2/ GAPDH) mRNA ratio. The amount of 32 P incorporation into each PCR product was Ͻ10% of total radioactivity of each primer added in the reaction mixture.
Reporter gene assay. The genomic fragment containing 888 bp of the 5Ј-upstream region and 25 bp of the 5Ј-untranslated region (UTR) of the mouse 5ЈD1 gene (mdio1) was obtained by PCR using Pfu DNA polymerase and the primers 5Ј-TCTAGAT-GATTCTACACTCTCTTCTGATCTCC-3Ј and 5Ј-AGCAGATC-TTCAGCACGGGGCAGAAGTGGTC-3Ј (MMU49862) (21) . The PCR products were cut by BglII, cloned into pGL3-Basic vector (Promega, Madison, WI) at the SmaI/BglII site, and named pGL3-D1. The mdio2 reporter construct pGL3-D2, containing 627 bp of the 5Ј-upstream region and 26 bp of the 5Ј-UTR, was obtained as described previously (30) .
For transient transfection experiments, ϳ5 ϫ 10 5 HC11 cells per well were cultured on 6-well plates 1 day before transfection. One microgram of reporter construct was cotransfected with 100 ng of an internal control, pRL-TK (Promega), by use of Lipofecto Amine Plus (Life Technologies), according to the manufacturer's instructions. Two days after transfection, cells were washed with PBS and treated with or without the combination of hormones and EGF, as described above. Luciferase assay was performed with the Dual-Luciferase kit (Promega) 48 h after treatment. The luciferase activity of the reporter gene was normalized by that of pGL3-Basic vector in each of the treated cells. pGL3-Promoter vector (Promega) containing an SV40 promoter was used as a positive control.
Statistical analysis. Data were examined by Student's ttest or by ANOVA, followed by Schemes's post hoc test when it was appropriate. A level of P Ͻ 0.05 was accepted as statistically significant. Data are presented as means Ϯ SE.
RESULTS
5ЈD activity and mRNA in HC11 cells. Initially, we examined 5ЈD activity in HC11 cells treated with insulin and EGF (IE) or with the combination of insulin, dexamethasone, and PRL (IDP). IE-treated cells had 5ЈD2 activity at the level of 137.1 Ϯ 32.4 fmol ⅐ mg protein Ϫ1 ⅐ h
Ϫ1
, whereas IDP-treated cells exhibited only 3.4% of 5ЈD2 activity in IE-treated cells (Fig. 1) . The enzyme activity of HC11 cell extracts was decreased by 1 M aurothioglucose (18.1 Ϯ 9.1%) but not by 1 mM PTU (100 Ϯ 5.4%) when added to the reaction mixture. No 5ЈD1 activity was detected in either IE-or IDP-treated cells. These data indicate that HC11 cells, like mammary glands of mouse, cow, and pig (16, 31) , possess 5ЈD2 activity that can be downregulated by IDP treatment.
We performed RT-PCR analysis for mouse 5ЈD1, 5ЈD2, and D3 mRNA in HC11 cells. A clear band for 5ЈD2 was observed in both IE-and IDP-treated cells ( Fig. 2A, top) . 5ЈD1 mRNA was also detected, but the intensity of the band was much weaker than that of 5ЈD2 bands (data not shown), whereas D3 mRNA was not detected in those cells under the conditions used (data not shown). Northern blot analysis for mouse 5ЈD2 mRNA was also performed, as described previously (30, 31) , using poly(A) ϩ RNA from cultured cells. The presence of a faint band, ϳ7.9 kb in length, was detected in IE-but not IDP-treated cells (data not shown). These data indicate that 5ЈD2 mRNA is present as a predominant type of 5ЈD in HC11 cells. Similar results were obtained in the previous studies of 5ЈD in the mammary gland of mouse, cow, and pig (16, 31) . Figure 2A (middle) also showed that mouse ␤-casein mRNA was induced by IDP but not by IE treatment, as previously reported (4).
Semiquantitative RT-PCR technique was used to investigate the level of 5ЈD2 mRNA in HC11 cells. As shown in Fig. 2, B and C, the D2/GAPDH mRNA ratio in IDP-treated cells was 18.4% of that in IE-treated cells. These results indicate that IDP treatment induces ␤-casein mRNA and reduces 5ЈD2 mRNA in HC11 cells.
Effects of lactogenic hormones and EGF on 5ЈD2 activity and mRNA in HC11 cells. To clarify which hormones or growth factor regulate mdio2 expression, HC11 cells were treated with various combinations of EGF and the lactogenic hormones insulin, dexamethasone, and PRL, and 5ЈD2 activity and the D2/GAPDH mRNA ratio were measured (Fig. 3) . In control cells treated without hormones and EGF, 5ЈD2 activity and the D2/GAPDH mRNA ratio were 72.2 Ϯ 20.0 fmol ⅐ mg protein Ϫ1 ⅐ h Ϫ1 and 0.410 Ϯ Fig. 1 . Type II 5Ј-deiodinase (5ЈD2) activity in HC11 cells. HC11 cells were treated in the presence of 5 g/ml insulin and 10 ng/ml epidermal growth factor (EGF) (IE) or 5 g/ml insulin, 1 M dexamethasone, and 5 g/ml prolactin (PRL) (IDP) for 2 days. Cell sonicates were assayed for 5ЈD activity as described in MATERIALS AND METHODS. Values are means Ϯ SE (n ϭ 7/group). *P Ͻ 0.005. Fig. 2 . RT-PCR analysis of mouse 5ЈD2 mRNA in HC11 cells. A: RT-PCR was performed using total RNA from HC11 cells treated with IE or IDP, as described in Fig. 1 ] and GAPDH sense primer (6 ϫ 10 4 cpm/5 pmol), as described in MATERIALS AND METHODS. PCR products for 5ЈD2 and GAPDH were separated by polyacrylamide gel electrophoresis. Lanes 1 and 2, IE-treated cells with or without RT, respectively. Lanes 3 and 4, IDP-treated cells with or without RT, respectively. Lane 5, H2O with all of the PCR reagents. C: relative level of 5ЈD2 mRNA. Radioactivities of the 5ЈD2 band were normalized against the corresponding value of the GAPDH band used in each reaction and were expressed as means Ϯ SE (n ϭ 4/group). *P Ͻ 0.05. 0.050, respectively. Addition of EGF increased both 5ЈD2 activity and the D2/GAPDH mRNA ratio about twofold (control vs. EGF and insulin vs. IE), suggesting that EGF upregulates mdio2 expression mainly at a pretranslational level. This effect of EGF was apparent at concentrations higher than 1 ng/ml (data not shown). On the other hand, addition of dexamethasone decreased 5ЈD2 activity to Ͻ10% and lowered the D2/GAPDH mRNA ratio to 20-30% of corresponding controls (control vs. dexamethasone, insulin vs. insulin ϩ dexamethasone, PRL vs. dexamethasone ϩ PRL, and insulin ϩ PRL vs. IDP). Addition of insulin or PRL did not change the level of 5ЈD2 activity or the D2/GAPDH mRNA ratio.
As shown in Fig. 4 , the inhibitory effect of dexamethasone on 5ЈD2 activity was concentration dependent. 5ЈD2 activity decreased ϳ40% in the presence of 10 Ϫ9 M dexamethasone and reached the lowest level, 4.0 Ϯ 2.7% of the control, in the presence of 10 Ϫ7 M dexamethasone. On the other hand, the level of the D2/ GAPDH mRNA ratio was decreased only 15% in the presence of 10 Ϫ9 M dexamethasone and reached the lowest level, 41.6 Ϯ 3.4% of control, at 10 Ϫ8 M dexamethasone. These data suggest that dexamethasone downregulates mdio2 expression at both pre-and posttranslational levels.
mdio2 Promoter activity in HC11 cells. To assess whether the effects of EGF and dexamethasone on mdio2 expression in HC11 cells are manifested at the level of transcription, we investigated the promoter activity of mdio2 in IE-and IDP-treated cells by transient transfection experiments. As shown in Fig. 5A , the pGL3-D2 construct (nucleotides Ϫ627 to ϩ26 of mdio2) exhibited promoter activity (17.8 Ϯ 0.4-fold of pGL3-Basic) in IE-treated cells. This promoter activity was significantly decreased by IDP treatment. On the other hand, the pGL3-D1 construct (nucleotides Ϫ888 to ϩ25 of mdio1) showed little promoter activity, whereas pGL3-Promoter showed a high promoter activity in both IE-and IDP-treated HC11 cells. These data indicate that mdio2 promoter activity is present in HC11 cells and that the difference of this promoter activity between IE and IDP treatment is specific.
Promoter activities of the pGL3-D2 construct were examined in HC11 cells treated with combinations of insulin, dexamethasone, PRL, and EGF (Fig. 5B) . The treatment with IE or EGF alone did not change mdio2 promoter activity compared with control cells treated without hormones and EGF. Dexamethasone significantly decreased the promoter activity to a lower level, similar to that obtained by IDP treatment. These data indicate that dexamethasone downregulates mdio2 expression, at least in part, at a transcriptional level. They also suggest that the proximal promoter (nucleotides Ϫ627 to ϩ26) of mdio2 contains the element(s) responsible for this downregulation.
DISCUSSION
In this study we have demonstrated that 5ЈD2 activity and mRNA are present in HC11 cells and that their levels are reduced in response to the lactogenic hormones insulin, GC, and PRL. These responses are similar to those of mouse mammary gland, the mdio2 expression of which is reduced during lactation (31) . These results suggest that HC11 cells can serve as a model for investigation of the regulatory mechanism of mdio2 expression in the mammary gland.
Administration of an excess amount of T 4 increases the synthesis of milk protein in the mammary gland (26) , but administration of an excess amount of T 3 decreases milk production (20) . Physiological concentrations of T 3 stimulate lobulo-alveolar development and PRL-induced synthesis of milk products in organ culture, but high concentrations of T 3 are inhibitory (34) . The mammary gland probably requires different amounts of intracellular T 3 in each reproductive stage. Levels of 5ЈD2 activity and mRNA are lower in the lactating mouse mammary gland than in the virgin or pregnant mouse (31) . IDP treatment, which induces cell differentiation and production of ␤-casein, reduced mdio2 expression in HC11 cells. It has been reported that the intracellular supply of T 3 is dependent on conversion from T 4 to T 3 by 5ЈD2 in astroglial cells (9) . We speculate that the lactating mouse mammary gland needs only a low but adequate amount of T 3 , which is mainly regulated by 5ЈD2.
EGF upregulated both 5ЈD2 activity and mRNA to a similar extent, suggesting pretranslational regulation. However, EGF failed to increase the luciferase activity of the pGL3-D2 construct (nucleotides Ϫ627 to ϩ26 of mdio2), suggesting that the 627-bp 5Ј-upstream region of mdio2 does not contain the element responsible for 5ЈD2 upregulation by EGF. We could not rule out the possibility that the farther upstream region may contain an EGF-responsive element. Alternatively, EGF may increase the stability and/or decrease the degradation of 5ЈD2 mRNA. It has been reported that EGF induces D3 activity and mRNA in cultured rat brown adipocytes (12, 13) . The studies of the effect of EGF on each type of deiodinase in different tissues will be needed to understand the regulatory mechanism of deiodinases and TH.
GC alone or in combination with insulin and/or PRL downregulated mdio2 expression in HC11 cells at both pre-and posttranslational levels. It has been reported that GC induces 5ЈD1 activity in mouse liver and both 5ЈD1 activity and mRNA in rat hepatocytes (22, 27) . GC reduces 5ЈD2 activity in human cultured placental cells (14) . These opposite effects of GC on 5ЈD1 and 5ЈD2 gene expression are similar to those of TH, T 4 , and T 3 , which increase 5ЈD1 but reduce 5ЈD2 (17, 35) . GC and TH may interact to regulate 5ЈD1 and 5ЈD2 expression. The reporter assay using the proximal promoter region of mdio2 indicated transcriptional downregulation of mdio2 expression by GC. Protein-protein interactions between the GC receptor and GATA-1 (8) and between the GC receptor and cAMP response element-binding protein (15) have been reported. In these cases, GC response elements are found near the GATA or cAMP response element. In some genes, such as the ␣-subunit of glycoprotein hormones, GC negatively regulates the transcription without consensus sequence to the GC response elements in their 5Ј-upstream regions (5) . It has been reported that the 5Ј-upstream region of mdio2 contains potential GATA and cAMP response elements but not the GC response element (30) . The sequence(s) in mdio2 responsible for downregulation by GC needs to be identified. In addition, it has been reported that a GC inhibitor suppresses the induction of 5ЈD2 activity in response to cold stress in the rat adrenal gland (3). These results suggest that the mode of regulation of 5ЈD2 by GC may vary among different tissues.
We thank Dr. Jacob Robbins, NIDDK, NIH, for helpful discussions and valuable comments. (mdio1 or mdio2/luciferase chimeric reporter gene, respectively) was transiently transfected into HC11 cells. Two days after transfection, cells were treated with either IE or IDP, as described in Fig. 1 , for 2 days. Luciferase activity was measured and expressed as fold induction of the pGL3-Basic, promoterless vector, in each treatment. The pGL3-Promoter vector was used as a positive control. Transfection efficiency was normalized by cotransfection of pRL-TK. Values are means Ϯ SE of 3 duplicate experiments. *P Ͻ 0.001. B: one microgram of pGL3-D2 was transiently transfected into HC11 cells. Two days after transfection, cells were treated with the indicated combinations of hormones and EGF, as described in Fig. 3 , or without hormones and EGF (C) for 2 days. Luciferase activity was measured and expressed as described above. Values are means Ϯ SE from 3 dishes. *P Ͻ 0.05 compared with C, IE, and E treatment.
